In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery (GLYPOCS)
Glycocalyx as Predictor of Complications After Cardiac Surgery
Sponsor: University Hospital, Rouen
Terminated
The period of authorization for effective inclusion has ended at 130 inclusions out of a theoretical 600.
Other terminated trials from University Hospital, Rouen
Other Cardiovascular Diseases trials with similar outcome
This observational or N/A phase trial investigates Cardiovascular Diseases and Endothelial Dysfunction and is currently terminated or withdrawn. University Hospital, Rouen leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Feb 2026 — Present [monthly]
Terminated
Status: Unknown → Terminated
-
Sep 2024 — Feb 2026 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Rouen
For direct contact, visit the study record on ClinicalTrials.gov .